The Horizon 2020 sub-programme MCSA RISE provides support of R&D activities by means of targeted staff exchanges of the partnering organisations. The 14 partners of the project MAGNAMED will exchange their knowledge and expertise in various aspects of bio-imaging methods, which will bring the newest trends in this field to VBCF.
13 summer/autumn fellowships of female students with the aim of initiating their scientific career. Their main goal is to work on further improvement of our services.
Brillouin Light Scattering Microspectroscopy for Biology and Biomedical Research & Applications (BioBrillouin)
The new COST Action aims at bringing together experts on Brillouin Light Scattering Spectroscopy and establishing a network which will be able to bring this novel technique to the field of life sciences and biomedicine.
Creating synergies between research infrastructures to stimulate innovation in the cross-border region
The project focuses on research infrastructures (RI) in the field of bio- and nanotechnology whose supportive role in both basic and applied science has become an indispensable part of scientific research. The main goal of the project is to prepare and validate a sustainable model of cross-border collaboration (Austria – Czech Republic) of RI that will ensure 1) effective exploitation of complementary equipment and expertise, 2) accessibility and promotion of the cross-border RI for regional users, both academic and industrial.
“I first came to the VBC in 2006 with the intention of staying only three or four years. Nine years later I am still here - the campus just keeps getting better!”
Peggy Stolt-Bergner, Protein Technologies
“VBC - where top expertise and cutting edge scientific infrastructure meets outstanding research and a great atmosphere.”
Jakub Jez, Plant Sciences Facility Head
“The Campus VBC is probably the most vibrant research site in Austria, so anyone interested in research would want to be here.”
Kareem Elsayad, Core Facility Head
“VBCF provides state-of-the-art equipment and dedicated experts. We help you to push your research further.”
Sylvia Badurek, Core Facility Head at Preclinical Phenotyping Facility
Who We Are
The Vienna BioCenter Core Facilities GmbH (VBCF) is a publicly funded non-profit research institute, situated at the Vienna Biocenter.
We offer access to state-of-the-art research infrastructure and scientific services. Our customers are academic research institutions and companies in the field of Life Sciences.
VBCF is open to all forms of scientific collaborations.
We offer cutting edge infrastructure and scientific services to enable our customers to compete at the forefront of science.
Passion for technology and science, continuous training and lifelong learning are what make VBCF staff the highly qualified experts we need to develop and operate our scientific infrastructure to the satisfaction of our customers.
We constantly scout for new and emerging technologies that can better address the research questions of our customers and aim for joint exploration.
We contribute to the most effective and efficient usage of public and private research funds by providing high-quality service and economies of scale through centralization.
VBCF acts as a communication platform and a joint repository of expertise. Technical knowledge and skills are preserved when researchers leave the Vienna Biocenter and are forwarded to the next generation of researchers.
We cooperate with other providers of research infrastructure to make technologies beyond our own portfolio accessible and to improve the quality of our services through benchmarking.
The Vienna Biocenter Core Facilities GmbH (VBCF) is a publicly funded non-profit research institute, situated at the Vienna Biocenter. VBCF was founded in 2010 as a limited liability company (GmbH) according to Austrian law. VBCF’s stakeholders are:
- Campus Vienna Biocenter Association (50%)
- Max F. Perutz Laboratories Support GmbH (25%)
- IMBA – Institute of Molecular Biotechnology (15%)
- GMI – Gregor Mendel Institute of Molecular Plant Biology (10%)
The operation of VBCF is funded by the Federal Ministry of Science, Research and Economy (bm.wfw) and the City of Vienna, by fees charged for delivered services and by additional research grants.
VBCF operates 11 scientific core facilities and the shared Child Care Center of the Vienna Biocenter as shown in the organization chart below.
Andreas Tiran took up his appointment as Managing Director of the VBCF in January 2011. He has extensive previous experience both as a researcher as well as a manager of scientific infrastructure.
|since 2011||Managing Director of Vienna Biocenter Core Facilities GmbH (VBCF), Vienna Biocenter, Austria|
|2004-2010||Director of the Center for Medical Research (ZMF), Medical University of Graz, Austria|
|2001-2004||Department Head at the Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Graz, Austria|
|2001||Associate Professor of Laboratory Medicine, University of Graz, Austria|
|1996-2001||Senior physician, deputy head, Department of Laboratory Medicine, University of Graz, Austria|
|1995||Board Certification Medical and Chemical Laboratory Diagnostic|
|1994-1996||Postdoc at the Department of Clinical Immunology, University Hospital of Groningen, The Netherlands|
|1989-1994||Resident at the Department of Internal Medicine, University of Graz, Austria|
|1982-1988||School of Medicine, University of Graz|
Authorized Representative of VBCF
Peggy Stolt-Bergner is Deputy Director and supports the Managing Director in the running of the institute.
|since 2014||Authorized Representative of VBCF|
|since 2011||Head of VBCF Protein Technologies Facility|
|2006-2011||IMP Fellow, Research Institute of Molecular Pathology|
|2004-2006||Postdoctoral Fellow, Max Planck Institute of Biophysics,|
|1999-2004||PhD, Biochemistry and Molecular Pharmacology, Harvard Medical School|
Barbara Miksch started at the VBCF from the very beginning in 2011 and is responsible for office administration, personnel administration and also external communications.
phone: +43 1 796 23 24 7000
Anastasia Manina joined the VBCF Administration in October 2014 as a controller. Her former international work experience is the perfect prerequisite for looking after the VBCF budget.
phone: +43 1 796 23 24 7011
Lada Fialova joined VBCF in March 2015 as grant manager. Her responsibility is to support and facilitate search for grant opportunities, grant applications, and grant management.
phone: +43 1 796 23 24 7013
Anita Kazda joined the VBCF in March 2017 as a junior grant manager. She supports the grant management of running grants and is responsible for their project management.
phone: +43 1 796 23 24 7014
Strategic Information Management
The Strategic Information Management (SIM) facility is responsible for a common VBCF IT strategy and centralizes the most important IT tasks of the VBCF. The goal of this facility is to concentrate, merge and plan all IT requirements of the VBVF and setup a service oriented architecture which facilitates the flow of information between the VBCF facilities and administration.
Thomas Micheler is head of Strategic Information Management (SIM) facility since summer 2013. He is responsible for a comprehensive IT strategy and IT controlling for the VBCF.
phone: +43 1 796 23 24 7023
Jan Sladek joined the Strategic Information Management (SIM) facility as software engineer in November 2013. He analyzes IT related requirements and develops/maintains VBCF wide information systems.
phone: +43 1 796 23 24 7228
VBCF has institutional collaborations with national and international research institutions, universities and other organizations with the following goals:
- Initiation of joint research projects
- Facilitation of staff exchange and development of joint training programs
- Improved access to cutting-edge technologies through resource sharing
Core For Life
Core for Life is an excellence initiative of six leading European core facility organizations. The common intention of the members of Core For Life is to collaborate in organizational and operational aspects of core facility management and scientific support of life science research. The Core For Life alliance envisions exploring and using the potential of bundling core facility expertise across institutions and countries.
Interview: Nature Med. 2013, 19, 802
NGS-Platform in Vienna
Next-generation sequencing technology is rapidly evolving and transforming both basic biological science and biomedicine. In order to remain competitive, research organizations in Vienna need to actively invest in this technology. The main goal of the proposed Joint Technology Platform for Next Generation Sequencing in Vienna is to avoid unnecessary overlaps and invest into the newest NGS technologies and equipment in a coordinated and cost-efficient way.
MRI-Platform in Vienna
Since 2013 the VBCF, the AIT Austrian Institute of Technology, the University of Veterinary Medicine and the Medical University of Vienna are collaborating to create a translational research platform for preclinical MRI imaging with the best technical, financial and scientific solutions. Through the collaboration of the most experienced scientific institutions in preclinical imaging in the area of Vienna, we aim to intensify MR research and explore the potential of synergetic effects.
Both VBCF and ISTA, the Institute of Science and Technology Austria, have committed themselves to coordinate the purchase of expensive instruments, to increase capacity usage and to bundle core facility expertise across the institutions. In particular VBCF and ISTA will join forces in providing access to state-of-the-art electron microscopy to their research groups.
In 2012, VBCF established a collaboration with AGES, the Austrian Agency for Health and Food Safety. Both institutions operate large-scale plant growth facilities with complementary technical specifications. The goal of the collaboration is the realization of research and development projects in life science by mutual use of technical scientific infrastructure, personnel, know-how, and operating resources.
Correlated Multimodal Imaging Node Austria (CMI)
The Correlated Multimodal Imaging Node Austria (CMI) is the official Austrian Euro-BioImaging (EuBI) initiative. EuBI is a research infrastructure project of the ESFRI Roadmap that aims at creating a pan-European network of advanced imaging facilities with open access to state-of-the-art imaging technology for all European life scientists. CMI was founded as a consortium of eight universities and research institutes in and around Vienna to establish a state-of-the-art multimodal imaging hub and Austrian EuBI node. As a centralized imaging platform with both highly specialized and holistic imaging approaches, it offers basic and high-end cutting-edge imaging technologies, numerous multimodal correlated imaging pipelines, and various support services to researchers on a national and international level. Imaging techniques at CMI span the entire resolution range of interest for preclinical and biological studies, and provide complementary sample information about structure, function and molecular composition. The more than 30 imaging techniques allow both in- and ex-vivo imaging and molecular analysis on the same specimen.
Please find out more here www.bioimaging-austria.at.
CEITEC is a scientific centre in the fields of life sciences, advanced materials and technologies whose aim is to establish itself as a recognized centre for basic as well as applied research. CEITEC offers a state-of-the-art infrastructure and great conditions to employ excellent researchers. It is a consortium whose partners include the most prominent universities and research institutes in Brno, Czech Republic: Masaryk University, Brno University of Technology, Mendel University in Brno, University of Veterinary and Pharmaceutical Sciences in Brno, Veterinary Research Institute and Institute of Physics of Materials of the Academy of Sciences of the Czech Republic. CEITEC works closely with the Region of South Moravia and the City of Brno to help increase local innovative capacity.
Basic overview: 6 partners, 7 research programs, 61 research groups, 557 researchers (2015), 25.000 m2 of new laboratories, 10 core facilities